Lack of funding may have been a hindrance in psychedelic research in the past but now with more resources available, advancements in the scientific understanding of psychedelics, growth in the pharmaceutical implementation of psychedelic medicines, and decriminalization allowing people to cultivate psychoactive plants and fungi for their own rituals and communities are all possible in the future.
This podcast discusses the excitement around the potential for increased funding and resources for scientific research into psychedelics over the next decade, with researchers like the host well-positioned to take advantage.
This podcast explores the use of medical grade MDMA and psilocybin in healing deep trauma, as well as the benefits of microdosing. The field of psychedelic medicine is emerging as a potential treatment for trauma and anxiety.
The potential benefits of psychedelic therapy in treating conditions like depression and PTSD are being explored, but there are concerns about profit motives and potential side effects. The underlying narrative of experiences may be key in restructuring them, but scientists are also striving to modify molecules to eliminate unwanted side effects.
The history of psychedelic research has been problematic in many ways and Timothy Leary has been blamed for many of the problems that emerged in relation to psychedelic drug use. However, the history of psychedelics was also profoundly elitist and it's important that there are people carefully monitoring what's happening in this important time in history.
New data shows that psychedelics can have immense positive impact when used by someone who knows how to utilize them in the right set and setting, and this meshes with the data from the 60s and 70s that showed their effectiveness. The data coming from labs and academic centers is powerfully positive, particularly for psilocybin and LSD.